ArticleDiabetes medications and cardiovascular outcome trials: Lessons learnedAuthor:Darren K. McGuire, MD, MHSc Publish date: October 2, 2017Drugs of several classes have demonstrated cardiovascular safety; empagliflozin carries a cardiovascular indication. Read More